Form 4 for CLX Clorox
Accepted 2023-09-15 00:00:00 ET · period of report 2023-09-13 · accession 0001225208-23-008968 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-15 | 2023-09-13 | CLX | Jacobsen Kevin B | EVP - CFO | A - Grant | $147.35 | +4,477 | 27.7K | +19% | +$659.7K | |
| M | 2023-09-15 | 2023-09-13 | CLX | Jacobsen Kevin B | EVP - CFO | F - Tax | $147.35 | -246 | 27.6K | -0.9% | -$36.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-13 | A | A | 4,477 | $147.35 | 27,701 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-13 | F | D | 140 | $147.35 | 27,455 | D | — | — | (F4) Includes 358 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
| 3 | Common | Common Stock | 2023-09-13 | F | D | 106 | $147.35 | 27,595 | D | — | — |